Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371709
Status:
COMPLETED
Last Update Posted:
2012-02-02
First Post:
2006-08-31
Brief Title:
TAXUS ATLAS TAXUS Liberté-SR Stent for the Treatment of de Novo Coronary Artery Lesions
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Study Overview
Official Title:
TAXUS ATLAS A Multi-center Single-arm Study of the TAXUS Liberté-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
TAXUS ATLAS is a global multi-center single-arm non-inferiority trial comparing results from patients treated with the TAXUS Liberté stent to an historical TAXUS Express control The control group is a case-matched blended population of TAXUS Express patients from the TAXUS IV and TAXUS V de novo clinical trials The objective of the study is to evaluate clinical outcomes of TAXUS Liberté-SR stent in de novo lesions and to assess the non-inferiority of TAXUS Liberté versus TAXUS Express The TAXUS Liberté-SR stent is hypothesized to have comparable safety and efficacy to the TAXUS Express stent
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| TAXUS ATLAS | None | None | None |